在18名患有严重动脉静脉形形的患者中,研究了thalidomide治疗的案例报告
Laurence M Boon1,2, Valérie Dekeuleneer3, Julien Coulie3
1Division of Plastic Surgery, Center for Vascular Anomalies, Cliniques universitaires Saint-Luc, UCLouvain, VASCERN VASCA European Reference Centre, Brussels, Belgium. Laurence.boon@uclouvain.be.
Nature cardiovascular research
|August 28, 2024
概括
沙利多米德通过减少疼痛和出血,有效地管理严重的动脉静脉形 (AVM). 这种血管生成抑制剂对难以治疗的血管异常有前途,尽管需要进一步研究.
科学领域:
- 血管外科 血管外科
- 医学瘤学 医学瘤学
- 皮肤病学 皮肤病学
背景情况:
- 动脉静脉形形 (AVMs) 是复杂的,破坏性的血管异常,往往不耐常规治疗.
- 异常的血管新生活性与AVM的发展有关.
- 已知thalidomide可以抑制血管增殖.
研究的目的:
- 评估thalidomide在患有严重,治疗不耐用的AVMs的患者的疗效和安全性.
- 评估thalidomide对AVM症状和血管性的影响.
主要方法:
- 一项前性观察性研究,涉及18名患有严重AVM的患者.
- 用血管生成抑制剂thalidomide进行治疗.
- 评估临床结果,包括疼痛,出血,和心脏功能.
- 动脉造影以评估血管变化.
主要成果:
- 所有患者都经历了快速的症状缓解 (疼痛减轻,止血,愈合).
- 在受影响的患者中心力衰竭得到缓解;在两个患者中观察到血管性减少.
- 一个AVM在19个月后显示完全治愈,随访8年.
- 在停止治疗后,八种AVM保持稳定,而四种复发.
结论:
- thalidomide在管理广泛,耐火性AVMs的症状方面表现出显著的有效性.
- 它为与AVMs相关的慢性疼痛,出血和瘤提供了潜在的治疗选择.
- 需要进一步的临床试验来确认thalidomide在AVM治疗中的安全性和有效性.
相关概念视频
Teratogenicity
4.2K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
Therapeutic Drug Monitoring: Affecting Factors
429
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
429
Rheumatic Heart Disease III: Medical Management
544
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
544
Cardiomyopathy II: Dilated Cardiomyopathy
790
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Cardiomyopathy V: Interprofessional Care
753
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753
Venous Thrombosis III: Interprofessional Care
482
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482


